Press releases

• Wednesday, 01 December 2004

  New ferring.com goes live

• Wednesday, 20 October 2004

  Mrs. Eva Paulsen, Ferring co-Founder, dies at 86

• Tuesday, 05 October 2004

  Degarelix, a new GnRH blocker from Ferring, shows rapid onset and

• Thursday, 26 August 2004

  Volume of urine as a useful indicator of Nocturnal Polyuria

• Sunday, 01 August 2004

  New nocturia section launched on MINIRIN.com

• Tuesday, 29 June 2004

  Ferring Kicks Off Campaign for Newest Product NORPROLAC at the International ESHRE Conference in Berlin

• Tuesday, 29 June 2004

  Experts confirm LH activity as an essential component in infertility treatment

• Thursday, 17 June 2004

  International experts recommend that children who want to be treated for bedwetting should be offered desmopressin or alarm therapy

• Monday, 10 May 2004

  Study reveals that women undergoing a cycle of IVF treatment with MENOPUR may have a significantly improved chance of becoming pregnant

• Sunday, 11 April 2004

  Ferring building receives award

• Friday, 02 April 2004

  Ferring appoints President of the Ferring Research Institute

• Monday, 15 March 2004

  Dr Eberhard Zinn, Ferring Board Member, dies at 66

• Friday, 27 February 2004

  Research by 2003 Nobel Laureate in Chemistry Fills in ‘Scientific Gaps’ Necessary for Ferring Researchers to Develop Incontinence Product Focusing on the Kidney

• Thursday, 22 January 2004

  Updates in Infertility Congress

• Thursday, 22 January 2004

  Additional data from a large multi-national trial indicates that women

• Monday, 12 January 2004

  Ferring Acquires DUPOMAR

• Tuesday, 06 January 2004

  Ferring Acquires NORPROLAC

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10

Email for media enquiries only.
For other queries, please see our Contact page.